Study | Treatement | No of patients | Biochemical responders (%) | PCR negative (%) | Histological improvement (%) | Rejection (%) |
---|---|---|---|---|---|---|
Wrightet al 47 | IFN 3MU×3/W (6 months) | 11 | 9 | 0 | 0 | 0 |
Wrightet al 48 | IFN 3MU×3/W (4 months) | 18 | 28 | 0 | 0 | 4 |
Feray et al 49 | IFN 3MU×3/W (6 months) | 14 | 23 | 0 | 14 | 35 |
Cattral et al 50 | Ribavirin (6 months) | 9 | 44 | 0 | 22 | 0 |
Gane et al 51 | Ribavirin (6 months) | 7 | 57 | 0 | 57 | 0 |
Bizollon et al 52 | IFN 3MU×3/W +ribavirin (6 months) | 21 | 100 | 48 | 100 | 0 |